• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用多价肽构建体使革兰氏阴性细菌膜选择性通透化以实现抗生素致敏

Selective Permeabilization of Gram-Negative Bacterial Membranes Using Multivalent Peptide Constructs for Antibiotic Sensitization.

作者信息

Chan Leslie W, Hern Kelsey E, Ngambenjawong Chayanon, Lee Katie, Kwon Ester J, Hung Deborah T, Bhatia Sangeeta N

机构信息

Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, United States.

Institute for Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, United States.

出版信息

ACS Infect Dis. 2021 Apr 9;7(4):721-732. doi: 10.1021/acsinfecdis.0c00805. Epub 2021 Mar 9.

DOI:10.1021/acsinfecdis.0c00805
PMID:33689277
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8043124/
Abstract

The drug-impermeable bacterial membrane in Gram-negative pathogens limits antibiotic access to intracellular drug targets. To expand our rapidly waning antibiotic arsenal, one approach is to improve the intracellular delivery of drugs with historically poor accumulation in Gram-negative bacteria. To do so, we engineered macromolecular potentiators to permeabilize the Gram-negative membrane to facilitate drug influx. Potentiators, known as WD40, were synthesized by grafting multiple copies of a cationic α-helical antimicrobial peptide, WLBU2, onto a dextran polymer scaffold. WD40 enabled drug uptake in the model pathogen , a capability that was not observed with unmodified WLBU2 peptide. WD40 was able to reduce minimum inhibitory concentrations of a drug panel by up to 3 orders of magnitude. Hydrophobic and highly three-dimensional antibiotics exhibited the greatest potentiation. Antibiotic activity was potentiated in several clinical strains and resulted in sensitization of drug-resistant strains to rifampin, a drug not previously used for Gram-negative infections.

摘要

革兰氏阴性病原体中药物不可渗透的细菌膜限制了抗生素进入细胞内的药物靶点。为了扩充我们迅速减少的抗生素库,一种方法是改善在革兰氏阴性细菌中积累历来较差的药物的细胞内递送。为此,我们设计了大分子增效剂,使革兰氏阴性膜通透性增加以促进药物流入。被称为WD40的增效剂是通过将多个阳离子α-螺旋抗菌肽WLBU2拷贝接枝到葡聚糖聚合物支架上合成的。WD40能够使模型病原体摄取药物,而未修饰的WLBU2肽则没有这种能力。WD40能够将一组药物的最低抑菌浓度降低多达3个数量级。疏水性和高度三维的抗生素表现出最大的增效作用。在几种临床菌株中抗生素活性得到增强,并导致耐药菌株对利福平敏感,利福平是一种以前未用于革兰氏阴性感染的药物。

相似文献

1
Selective Permeabilization of Gram-Negative Bacterial Membranes Using Multivalent Peptide Constructs for Antibiotic Sensitization.使用多价肽构建体使革兰氏阴性细菌膜选择性通透化以实现抗生素致敏
ACS Infect Dis. 2021 Apr 9;7(4):721-732. doi: 10.1021/acsinfecdis.0c00805. Epub 2021 Mar 9.
2
Newly designed antimicrobial peptides with potent bioactivity and enhanced cell selectivity prevent and reverse rifampin resistance in Gram-negative bacteria.新设计的具有强大生物活性和增强细胞选择性的抗菌肽可预防和逆转革兰氏阴性菌中的利福平耐药性。
Eur J Pharm Sci. 2021 Mar 1;158:105665. doi: 10.1016/j.ejps.2020.105665. Epub 2020 Dec 4.
3
Precision Dosing of Antibiotics and Potentiators by Hypoxia-Responsive Nanoparticles for Overcoming Antibiotic Resistance in Gram-Negative Bacteria.缺氧响应性纳米颗粒精准给药抗生素和增效剂以克服革兰氏阴性菌的抗生素耐药性
ACS Macro Lett. 2023 Sep 19;12(9):1193-1200. doi: 10.1021/acsmacrolett.3c00365. Epub 2023 Aug 17.
4
Ultra-Short Cyclized β-Boomerang Peptides: Structures, Interactions with Lipopolysaccharide, Antibiotic Potentiator and Wound Healing.超短环化 β-回形针肽:结构、与脂多糖的相互作用、抗生素增效剂和伤口愈合。
Int J Mol Sci. 2022 Dec 23;24(1):263. doi: 10.3390/ijms24010263.
5
Repurposing azithromycin and rifampicin against Gram-negative pathogens by combination with peptide potentiators.通过与肽增效剂联合使用,重新利用阿奇霉素和利福平对抗革兰氏阴性病原体。
Int J Antimicrob Agents. 2019 Jun;53(6):868-872. doi: 10.1016/j.ijantimicag.2018.10.025. Epub 2018 Nov 14.
6
Potentiation of Antibiotic Activity by a Novel Cationic Peptide: Potency and Spectrum of Activity of SPR741.新型阳离子肽增强抗生素活性:SPR741的活性强度及活性谱
Antimicrob Agents Chemother. 2017 Jul 25;61(8). doi: 10.1128/AAC.00200-17. Print 2017 Aug.
7
Arg-biodynamers as antibiotic potentiators through interacting with Gram-negative outer membrane lipopolysaccharides.通过与革兰氏阴性外膜脂多糖相互作用,Arg-生物动力剂成为抗生素增效剂。
Eur J Pharm Biopharm. 2024 Jul;200:114336. doi: 10.1016/j.ejpb.2024.114336. Epub 2024 May 23.
8
Antimicrobial Peptide Novicidin Synergizes with Rifampin, Ceftriaxone, and Ceftazidime against Antibiotic-Resistant Enterobacteriaceae In Vitro.抗菌肽诺维菌素与利福平、头孢曲松和头孢他啶协同作用,体外抗耐抗生素肠杆菌科细菌。
Antimicrob Agents Chemother. 2015 Oct;59(10):6233-40. doi: 10.1128/AAC.01245-15. Epub 2015 Jul 27.
9
Repurposing Azithromycin and Rifampicin Against Gram-Negative Pathogens by Combination With Peptidomimetics.通过与肽模拟物联合使用,将阿奇霉素和利福平重新用于对抗革兰氏阴性病原体。
Front Cell Infect Microbiol. 2019 Jul 2;9:236. doi: 10.3389/fcimb.2019.00236. eCollection 2019.
10
Outer Membrane Disruption Overcomes Intrinsic, Acquired, and Spontaneous Antibiotic Resistance.外膜破坏克服固有、获得和自发的抗生素耐药性。
mBio. 2020 Sep 22;11(5):e01615-20. doi: 10.1128/mBio.01615-20.

引用本文的文献

1
Development of Broad-Spectrum Antimicrobial Peptides through the Conjugation of FtsZ-Binding and Cell-Penetrating Peptides.通过FtsZ结合肽与细胞穿透肽的缀合开发广谱抗菌肽
ACS Infect Dis. 2025 Aug 8;11(8):2190-2204. doi: 10.1021/acsinfecdis.5c00220. Epub 2025 Jul 24.
2
Antibiotic potentiators as a promising strategy for combating antibiotic resistance.抗生素增效剂作为对抗抗生素耐药性的一种有前景的策略。
NPJ Antimicrob Resist. 2025 Jun 6;3(1):53. doi: 10.1038/s44259-025-00112-4.
3
Investigating the effects of microwave plasma on bacterial cell structures, viability, and membrane integrity.

本文引用的文献

1
Development and Challenges of Antimicrobial Peptides for Therapeutic Applications.用于治疗应用的抗菌肽的发展与挑战
Antibiotics (Basel). 2020 Jan 13;9(1):24. doi: 10.3390/antibiotics9010024.
2
Potentiation of Antibiotics against Gram-Negative Bacteria by Polymyxin B Analogue SPR741 from Unique Perturbation of the Outer Membrane.多黏菌素 B 类似物 SPR741 通过独特扰动外膜增强抗革兰氏阴性菌抗生素的作用。
ACS Infect Dis. 2020 Jun 12;6(6):1405-1412. doi: 10.1021/acsinfecdis.9b00159. Epub 2019 Oct 23.
3
Safety, Tolerability, Pharmacokinetics, and Drug Interaction Potential of SPR741, an Intravenous Potentiator, after Single and Multiple Ascending Doses and When Combined with β-Lactam Antibiotics in Healthy Subjects.
研究微波等离子体对细菌细胞结构、活力和膜完整性的影响。
Sci Rep. 2025 May 24;15(1):18052. doi: 10.1038/s41598-025-02312-4.
4
New Antimicrobial Strategies to Treat Multi-Drug Resistant Infections Caused by Gram-Negatives in Cystic Fibrosis.治疗囊性纤维化中革兰氏阴性菌引起的多重耐药感染的新抗菌策略
Antibiotics (Basel). 2024 Jan 11;13(1):71. doi: 10.3390/antibiotics13010071.
5
Pathogenic bacteria and treatment resistance in older cardiovascular disease patients with lung infection and risk prediction model.老年心血管疾病合并肺部感染患者的病原菌及治疗耐药性与风险预测模型
Open Life Sci. 2023 Dec 13;18(1):20220756. doi: 10.1515/biol-2022-0756. eCollection 2023.
6
Towards Antibacterial Agents: Synthesis and Biological Activity of Multivalent Amide Derivatives of Thiacalix[4]arene with Hydroxyl and Amine Groups.迈向抗菌剂:含羟基和胺基的硫杂杯[4]芳烃多价酰胺衍生物的合成与生物活性
Pharmaceutics. 2023 Dec 5;15(12):2731. doi: 10.3390/pharmaceutics15122731.
7
Proline-Hinged α-Helical Peptides Sensitize Gram-Positive Antibiotics, Expanding Their Physicochemical Properties to Be Used as Gram-Negative Antibiotics.脯氨酸铰链的 α-螺旋肽使革兰氏阳性抗生素敏感,扩大了它们的物理化学性质,可作为革兰氏阴性抗生素使用。
J Med Chem. 2024 Feb 8;67(3):1825-1842. doi: 10.1021/acs.jmedchem.3c01473. Epub 2023 Dec 21.
8
Cationic Polymers Enable Internalization of Negatively Charged Chemical Probes into Bacteria.阳离子聚合物使带负电荷的化学探针进入细菌内。
ACS Chem Biol. 2023 Sep 15;18(9):2063-2072. doi: 10.1021/acschembio.3c00351. Epub 2023 Sep 6.
9
Recent Progress in the Characterization, Synthesis, Delivery Procedures, Treatment Strategies, and Precision of Antimicrobial Peptides.近年来抗菌肽的特性、合成、传递程序、治疗策略和精准度的研究进展。
Int J Mol Sci. 2023 Jul 24;24(14):11864. doi: 10.3390/ijms241411864.
10
Ultra-Short Cyclized β-Boomerang Peptides: Structures, Interactions with Lipopolysaccharide, Antibiotic Potentiator and Wound Healing.超短环化 β-回形针肽:结构、与脂多糖的相互作用、抗生素增效剂和伤口愈合。
Int J Mol Sci. 2022 Dec 23;24(1):263. doi: 10.3390/ijms24010263.
SPR741(一种静脉增强剂)在健康受试者中单次和多次递增剂量以及与β-内酰胺类抗生素联合用药时的安全性、耐受性、药代动力学和药物相互作用潜力。
Antimicrob Agents Chemother. 2019 Aug 23;63(9). doi: 10.1128/AAC.00892-19. Print 2019 Sep.
4
Emerging Strategies to Combat ESKAPE Pathogens in the Era of Antimicrobial Resistance: A Review.抗菌药物耐药时代对抗ESKAPE病原体的新兴策略:综述
Front Microbiol. 2019 Apr 1;10:539. doi: 10.3389/fmicb.2019.00539. eCollection 2019.
5
Elastic behavior of model membranes with antimicrobial peptides depends on lipid specificity and d-enantiomers.模型膜中具有抗菌肽的弹性行为取决于脂质特异性和 D-对映异构体。
Soft Matter. 2019 Feb 20;15(8):1860-1868. doi: 10.1039/c8sm02180e.
6
Cell-selectivity of tryptophan and tyrosine in amphiphilic α-helical antimicrobial peptides against drug-resistant bacteria.两亲性 α-螺旋抗菌肽中色氨酸和酪氨酸对耐药菌的细胞选择性。
Biochem Biophys Res Commun. 2018 Oct 28;505(2):478-484. doi: 10.1016/j.bbrc.2018.09.095. Epub 2018 Sep 27.
7
The challenge of converting Gram-positive-only compounds into broad-spectrum antibiotics.将仅针对革兰氏阳性菌的化合物转化为广谱抗生素面临的挑战。
Ann N Y Acad Sci. 2019 Jan;1435(1):18-38. doi: 10.1111/nyas.13598. Epub 2018 Feb 15.
8
SPR741, an Antibiotic Adjuvant, Potentiates the and Activity of Rifampin against Clinically Relevant Extensively Drug-Resistant Acinetobacter baumannii.SPR741,一种抗生素佐剂,增强利福平对临床相关广泛耐药鲍曼不动杆菌的 和 活性。
Antimicrob Agents Chemother. 2017 Nov 22;61(12). doi: 10.1128/AAC.01239-17. Print 2017 Dec.
9
Predictive compound accumulation rules yield a broad-spectrum antibiotic.预测性化合物积累规则产生一种广谱抗生素。
Nature. 2017 May 18;545(7654):299-304. doi: 10.1038/nature22308. Epub 2017 May 10.
10
Prevalence of Gram-negative bacteria in ventilator-associated pneumonia in neonatal intensive care units: a systematic review and meta-analysis protocol.新生儿重症监护病房呼吸机相关性肺炎中革兰氏阴性菌的患病率:一项系统评价和荟萃分析方案
BMJ Open. 2016 Oct 11;6(10):e012298. doi: 10.1136/bmjopen-2016-012298.